Neogen Corporation Interest Income, Other
Neogen Corporation (NEOG) reported Interest Income, Other of $592.00 thousand for the 3-month period ending 2025-11-30, per its 10-Q filed 2026-01-08.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeOther · last filed 2026-01-08
- Neogen Corporation interest income, other for the quarter ending 2025-11-30 was $592.00K, a 23.51% decline year-over-year.
- Neogen Corporation interest income, other for the quarter ending 2025-08-31 was $918.00K, a 7.55% decline year-over-year.
- Neogen Corporation interest income, other for the quarter ending 2025-05-31 was $644.00K, a 41.29% decline year-over-year.
- Neogen Corporation interest income, other for the quarter ending 2025-02-28 was $699.00K, a 56.64% decline year-over-year.
- Neogen Corporation interest income, other for fiscal 2025 was $3.11M, a 51.12% decline from fiscal 2024.
- Neogen Corporation interest income, other for fiscal 2024 was $6.36M, a 100.95% increase from fiscal 2023.
- Neogen Corporation interest income, other for fiscal 2023 was $3.17M.
| Period end | Interest Income, Other 3 month | Interest Income, Other 6 month | Interest Income, Other 9 month | Interest Income, Other 12 month |
|---|---|---|---|---|
| 2025-11-30 | $592.00K 10-Q · filed 2026-01-08 | $1.51M 10-Q · filed 2026-01-08 | $2.15M derived: sum of 3 quarters · filed 2026-01-08 | $2.85M derived: sum of 4 quarters · filed 2026-01-08 |
| 2025-08-31 | $918.00K 10-Q · filed 2025-10-09 | $1.56M derived: sum of 2 quarters · filed 2025-10-09 | $2.26M derived: sum of 3 quarters · filed 2025-10-09 | $3.04M derived: sum of 4 quarters · filed 2026-01-08 |
| 2025-05-31 | $644.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-30 | $1.34M derived: sum of 2 quarters · filed 2025-07-30 | $2.12M derived: sum of 3 quarters · filed 2026-01-08 | $3.11M 10-K · filed 2025-07-30 |
| 2025-02-28 | $699.00K 10-Q · filed 2025-04-09 | $1.47M derived: sum of 2 quarters · filed 2026-01-08 | $2.47M 10-Q · filed 2025-04-09 | $3.56M derived: sum of 4 quarters · filed 2026-01-08 |
| 2024-11-30 | $774.00K 10-Q · filed 2026-01-08 | $1.77M 10-Q · filed 2026-01-08 | $2.86M derived: sum of 3 quarters · filed 2026-01-08 | $4.48M derived: sum of 4 quarters · filed 2026-01-08 |
| 2024-08-31 | $993.00K 10-Q · filed 2025-10-09 | $2.09M derived: sum of 2 quarters · filed 2025-10-09 | $3.70M derived: sum of 3 quarters · filed 2025-10-09 | $5.57M derived: sum of 4 quarters · filed 2025-10-09 |
| 2024-05-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-30 | $2.71M derived: sum of 2 quarters · filed 2025-07-30 | $4.57M derived: sum of 3 quarters · filed 2025-07-30 | $6.36M 10-K · filed 2025-07-30 |
| 2024-02-29 | $1.61M 10-Q · filed 2025-04-09 | $3.48M derived: sum of 2 quarters · filed 2025-04-09 | $5.26M 10-Q · filed 2025-04-09 | $6.27M derived: sum of 4 quarters · filed 2025-07-30 |
| 2023-11-30 | $1.86M 10-Q · filed 2025-01-15 | $3.65M 10-Q · filed 2025-01-15 | $4.66M derived: sum of 3 quarters · filed 2025-07-30 | $5.30M derived: sum of 4 quarters · filed 2025-07-30 |
| 2023-08-31 | $1.79M 10-Q · filed 2024-10-10 | $2.79M derived: sum of 2 quarters · filed 2025-07-30 | $3.43M derived: sum of 3 quarters · filed 2025-07-30 | $3.99M derived: sum of 4 quarters · filed 2025-07-30 |
| 2023-05-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-30 | $1.64M derived: sum of 2 quarters · filed 2025-07-30 | $2.20M derived: sum of 3 quarters · filed 2025-07-30 | $3.17M 10-K · filed 2025-07-30 |
| 2023-02-28 | $640.00K 10-Q · filed 2024-04-09 | $1.19M derived: sum of 2 quarters · filed 2024-04-09 | $2.16M 10-Q · filed 2024-04-09 | |
| 2022-11-30 | $553.00K 10-Q · filed 2024-01-09 | $1.52M 10-Q · filed 2024-01-09 | ||
| 2022-08-31 | $971.00K 10-Q · filed 2023-10-10 | |||
| 2022-02-28 | $349.00K 10-Q · filed 2023-04-04 | $595.00K derived: sum of 2 quarters · filed 2023-04-04 | $804.00K 10-Q · filed 2023-04-04 | |
| 2021-11-30 | $246.00K 10-Q · filed 2023-01-09 | $455.00K 10-Q · filed 2023-01-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |